Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus.
[familial mediterranean fever]
Tacrolimus
is
a
CYP
3
A
4
inhibitor
and
can
alter
colchicine
metabolism
.
In
this
study
,
we
aimed
to
evaluate
plasma
colchicine
levels
in
different
stages
of
kidney
disease
as
well
as
in
kidney
transplant
(
KTx
)
recipients
using
tacrolimus
.
This
study
included
six
familial
Mediterranean
fever
(
FMF
)
patients
with
normal
glomerular
filtration
rate
(
GFR
)
as
controls
,
three
patients
with
low
GFR
,
six
FMF
patients
on
hemodialysis
(
HD
)
,
and
six
FMF
patients
who
were
KTx
recipients
using
tacrolimus
.
After
a
three
-d
washout
period
,
plasma
colchicine
levels
were
measured
at
0
(
pre-dose
)
,
one
,
two
,
four
,
eight
,
and
24
Â
h
post-dose
of
1
Â
mg
oral
colchicine
.
Area
under
the
curve
0
-
24
Â
h
(
AUC
0
-
24
)
and
maximum
concentration
(
Cmax
)
were
evaluated
and
compared
between
the
groups
.
Colchicine
AUC
0
-
24
was
six-fold
higher
in
HD
(
p
Â
<
Â
0
.
001
)
and
three-fold
higher
in
KTx
recipients
(
p
Â
<
Â
0
.
001
)
when
compared
to
the
control
.
The
low
GFR
group
had
mildly
higher
AUC
0
-
24
than
the
control
group
.
Cmax
levels
were
also
higher
in
HD
(
p
Â
=
Â
0
.
011
)
and
KTx
recipient
(
p
Â
=
Â
0
.
06
)
groups
and
mildly
elevated
in
low
GFR
patients
in
comparison
with
controls
.
Colchicine
AUC
0
-
24
and
Cmax
were
significantly
increased
in
HD
patients
and
KTx
recipients
using
tacrolimus
.
Therefore
,
dose
adjustments
are
needed
to
avoid
toxicity
in
both
circumstances
.
Diseases
Validation
Diseases presenting
"fever"
symptom
22q11.2 deletion syndrome
acute rheumatic fever
alexander disease
allergic bronchopulmonary aspergillosis
canavan disease
carcinoma of the gallbladder
child syndrome
congenital toxoplasmosis
cushing syndrome
cystinuria
dracunculiasis
erdheim-chester disease
esophageal adenocarcinoma
esophageal carcinoma
familial mediterranean fever
focal myositis
hodgkin lymphoma, classical
lamellar ichthyosis
legionellosis
locked-in syndrome
malignant atrophic papulosis
neonatal adrenoleukodystrophy
neuralgic amyotrophy
oculocutaneous albinism
papillon-lefèvre syndrome
pyomyositis
pyruvate dehydrogenase deficiency
scrub typhus
severe combined immunodeficiency
sneddon syndrome
systemic capillary leak syndrome
triple a syndrome
typhoid
waldenström macroglobulinemia
wolf-hirschhorn syndrome
This symptom has already been validated